Reodar - the solution affecting electrolytic balance for improvement of a capillary blood-groove for the purpose of prevention and treatment of traumatic, operational, hemolytic, toxic and burn shock, at sharp blood loss, a burn disease; at the infectious diseases which are followed by intoxication at exacerbation of chronic hepatitis; at sepsis; for preoperative preparation and during the postoperative period; for improvement of arterial and venous circulation for the purpose of prevention of thromboses, thrombophlebitises, endarteritis, a Raynaud's disease.

Structure

• active ingredients: 1 ml of solution contains sorbitol 60.0 mg, sodium (S) - a solution lactate (in terms of 100% substance) 19.0 mg, sodium of chloride of 6.0 mg, dihydrate Calcii chloridum (in terms of Calcii chloridum) 0.1 mg, potassium of chloride of 0.3 mg, hexahydrate chloride magnesium (in terms of magnesium chloride) 0.2 mg;
• excipient: water for injections.

Contraindication

Individual hypersensitivity to medicine components. Reodar not to apply at an alkalosis and also in cases when injection of large volumes of liquid (a cerebral hemorrhage, a thrombembolia, a cardiovascular decompensation, arterial hypertension of the III degree, dekompensirovanny heart diseases, a terminal renal failure is contraindicated.

Side reactions

from digestive tract: nausea, vomiting.

from nervous system: tremor, headaches, dizziness, general weakness.

from a cardiovascular system: increase or decrease in the ABP, tachycardia, short wind, Crocq's disease.

from the immune system: anaphylactoid reactions, Quincke's disease, hyperthermia.

from skin and hypodermic cellulose: skin rash, small tortoiseshell, feeling of an itch.

General violations and reactions in the injection site: changes in the injection site, including pain and burning.

Reodar® to enter

adult inside by drop infusion with a speed of 40-60 thaws a minute. If necessary jet introduction of medicine after conducting test by drop introduction with a speed of 30 kr / min. is allowed. After introduction of 15 drops the use of medicine should be stopped, and in 3 min., in the absence of reaction, Reodar to enter struyno.

adult to enter

At traumatic, burn, postoperative and hemolytic shocks on 600-1000 ml (10-15 ml/kg of body weight of the patient) once and repeatedly on 600-1000 ml (10-15 ml/kg of body weight). then by drop infusion. In chronic hepatitis the adult to enter 400 ml (6-7 ml/kg of body weight) by drop infusion. At sharp blood loss the adult to enter 1500-1800 ml (up to 25 ml/kg of body weight). In this case infusions to Reodar are recommended to be carried out at a dopitalny stage in the specialized ambulance car. During the preoperative period and after various surgical interventions – in a dose of 400 ml (6-7 ml/kg of body weight) by drop infusion within 3-5 days. In tromboobliteriruyushchy diseases of blood vessels at the rate of 8-10 ml/kg of body weight by drop infusion, repeatedly, every other day, up to 10 infusions on a course of treatment.

Feature of application

Use during pregnancy or feeding by a breast

Data on contraindications during pregnancy or feeding.

Children

Data on experience of application.

Ability to influence speed of response at control of motor transport or other mechanisms

As medicine is applied in the conditions of a hospital, there are no data on such influences.

Overdose

alkalosis phenomena which quickly disappear independently at the immediate termination of administration of medicine, sometimes collapse, dehydration (due to strengthening of a diuresis) Arise. When speeding introduction the development of tachycardia, increase in the ABP, short wind, a headache, pain behind a breast, an abdominal pain is possible. The specified symptoms quickly disappear after the termination or reduction in the rate of administration of solution.

not to apply

as solvent carrier to other medicines.

Storage conditions

to Store

at a temperature not above 25 °C. Not to freeze.

to Store

out of children's reach.